Claudette sells MNKD 8.16: Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market
With its FDA approved super rapid acting insulin, Afrezza, that could mimic the actions of healthy pancreas, Mannkind Corporation (NASDAQ: MNKD) is already positioned it self to become the new leader in this huge insulin market. Diabetic complications such ... ...
52 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home